Pharmafile Logo
Pharmafocus logo
Advanced Search

Long awaited diabetes NSF in sight, but no new money

October 22, 2003

News

Bad omens for NHS patient involvement

October 22, 2003

The exclusion of frontline NHS staff from early work on patients' forums does not bode well for the future of …

News

PowderJect won’t be ‘sold on the cheap’

October 22, 2003

News

EU suspends Pfizer/Pharmacia merger review

October 22, 2003

The European Union has put on hold its review of the proposed merger of Pfizer and Pharmacia merger, delaying the …

News

Local pharmaceutical services

October 22, 2003
Sales and Marketing LPS, local pharmaceutical services, medicines management, pharmacy

Pharmacists are recognised by the Government as having a crucial role to play in developing better patient care within the …

Feature

Dolly’s PR merges into new communications consultants

October 22, 2003

News

Garnier pay defeat signals shareholder power shift

October 22, 2003

News

S-P’s Zetia gains US approval

October 22, 2003

Schering-Plough's Zetia, the first in a new class of cholesterol-lowering drugs that slow intestinal absorption of cholesterol has gained FDA …

News

ABPI collaborates on diabetes website for Scotland

October 22, 2003

News

Pharma gets smart & lean

October 22, 2003
Research and Development pharma, strategy

Pharmaceutical companies need to transform themselves into more flexible and connected entities and  given the financial pressures on the sector …

Feature

EDC – turning the corner?

October 22, 2003
Research and Development EDC, drug development, electronic data capture, technology

Electronic Data Capture is a way of eliminating paper in the data collection process by capturing the data directly into …

Feature

European biotech – surviving the storm

October 22, 2003
Research and Development Europe, biotech, investment

Flexibility and constant adjustment are necessary to survive one of the toughest times in the history of the industry.There have …

Feature

A smoother ride to market

October 22, 2003
Research and Development clinical development, patient recruitment

The concepts of the 'business case' and 'performance management' have become popular even outside business circles, but clinical trials for …

Feature

NHS pay rise linked to reform

October 22, 2003

Workers throughout the NHS are to receive substantial pay rises in return for undergoing radical ob evaluationreviews over the next …

News

Novartis files COX-II contender amid class safety concerns

October 22, 2003

Novartis has submitted its COX-II inhibitor Prexige to US and European regulators with data from 13,000 clinical trial patients to …

News

Supplementary prescribing gets go ahead

October 22, 2003

Thousands of trained pharmacists and nurses will be able to prescribe drugs for chronic diseases by late 2004, the Government …

News

Increase marketing RoI or cut back, analysts warn

October 22, 2003

Pharmaceutical companies must make their sales and marketing more cost-effective or cut back, according to a new report.Analysts Datamonitor warn …

News

OGS extends Actelion relationship as Zavesca approved

October 22, 2003

Oxford GlycoSciences has announced the EU approval of its first product, Zavesca, and an extension to its co-marketing agreement with …

News

Red tape could suffocate European clinical trials

October 22, 2003

New measures intended to improve the competitiveness of clinical trials in Europe could have the opposite effect, a leading research …

News

Garnier to concede on pay demands

October 22, 2003

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026